MEDICAID NOTICE: Lurie Children’s continues to serve all patients enrolled in Medicaid. As a safety-net hospital, we will continue providing high-quality care to every child who needs us.

AVISO SOBRE MEDICAID: Lurie Children’s continúa atendiendo a todos los pacientes inscritos en Medicaid. Como hospital perteneciente a la red de protección social, continuaremos brindando atención de alta calidad a cada niño que nos necesite.

PHOX2B gene testing is performed by the Molecular Diagnostic Laboratory at Lurie Children's. For the sequencing test, the entire coding region together with the intronic splice sites are sequenced and analyzed. This test detects polyalanine-repeat mutations as well as known and novel non-polyalanine repeat mutations.

Deletions of PHOX2B have recently been associated with Congenital Central Hypoventilation Syndrome (CCHS)-like symptoms, although the genotype-phenotype association is not yet clear. An estimated 2-5% of PHOX2B mutations will be a large deletion of the entire gene or part of the gene that cannot be detected by sequencing. Therefore, we have validated another technique to detect deletions and duplications in PHOX2B called Multiplex Ligation-Dependent Probe Amplification (MLPA). All identified deletion/duplication abnormalities are also tested by high-density array comparative genomic hybridization to better define the region involved.

For further clarification about these tests and their clinical utility or about CCHS, please contact Dr. Weese-Mayer at DWeese-Mayer@luriechildrens.org.

Download the PHOX2B Requisition Form and the PHOX2B Patient Information Billing Form.

Make an Appointment

Call to make an appointment with our autonomic medicine team.